158 related articles for article (PubMed ID: 36241752)
21. Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center retrospective study.
Matsumoto I; Murakami Y; Shinzeki M; Asari S; Goto T; Tani M; Motoi F; Uemura K; Sho M; Satoi S; Honda G; Yamaue H; Unno M; Akahori T; Kwon AH; Kurata M; Ajiki T; Fukumoto T; Ku Y
Pancreatology; 2015; 15(6):674-80. PubMed ID: 26467797
[TBL] [Abstract][Full Text] [Related]
22. Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: Stages of progression and potential benefits of early intervention: A retrospective study.
Singh DP; Sheedy S; Goenka AH; Wells M; Lee NJ; Barlow J; Sharma A; Kandlakunta H; Chandra S; Garg SK; Majumder S; Levy MJ; Takahashi N; Chari ST
Pancreatology; 2020 Oct; 20(7):1495-1501. PubMed ID: 32950386
[TBL] [Abstract][Full Text] [Related]
23. Critical issues in pathologic evaluation of pancreatic ductal adenocarcinoma resected after neoadjuvant treatment: a narrative review.
Taherian M; Wang H
Chin Clin Oncol; 2022 Jun; 11(3):21. PubMed ID: 35726190
[TBL] [Abstract][Full Text] [Related]
24. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
Dumont R; Puleo F; Collignon J; Meurisse N; Chavez M; Seidel L; Gast P; Polus M; Loly C; Delvenne P; Meunier P; Hustinx R; Deroover A; Detry O; Louis E; Martinive P; Van Daele D
Acta Gastroenterol Belg; 2017; 80(4):451-461. PubMed ID: 29560639
[TBL] [Abstract][Full Text] [Related]
25. Imaging Assessment of Pancreatic Cancer Resectability After Neoadjuvant Therapy:
Soloff EV; Al-Hawary MM; Desser TS; Fishman EK; Minter RM; Zins M
AJR Am J Roentgenol; 2022 Apr; 218(4):570-581. PubMed ID: 34851713
[TBL] [Abstract][Full Text] [Related]
26. Postoperative surveillance of pancreatic cancer patients.
Daamen LA; Groot VP; Intven MPW; Besselink MG; Busch OR; Koerkamp BG; Mohammad NH; Hermans JJ; van Laarhoven HWM; Nuyttens JJ; Wilmink JW; van Santvoort HC; Molenaar IQ; Stommel MWJ;
Eur J Surg Oncol; 2019 Oct; 45(10):1770-1777. PubMed ID: 31204168
[TBL] [Abstract][Full Text] [Related]
27. CA19-9 on Postoperative Surveillance in Pancreatic Ductal Adenocarcinoma: Predicting Recurrence and Changing Prognosis over Time.
Rieser CJ; Zenati M; Hamad A; Al Abbas AI; Bahary N; Zureikat AH; Zeh HJ; Hogg ME
Ann Surg Oncol; 2018 Nov; 25(12):3483-3491. PubMed ID: 29786131
[TBL] [Abstract][Full Text] [Related]
28. The canary in the coal mine: the growth of patient-derived tumorgrafts in mice predicts clinical recurrence after surgical resection of pancreatic ductal adenocarcinoma.
Thomas RM; Truty MJ; Kim M; Kang Y; Zhang R; Chatterjee D; Katz MH; Fleming JB
Ann Surg Oncol; 2015; 22(6):1884-92. PubMed ID: 25404477
[TBL] [Abstract][Full Text] [Related]
29. Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma.
Malleo G; Maggino L; Ferrone CR; Marchegiani G; Luchini C; Mino-Kenudson M; Paiella S; Qadan M; Scarpa A; Lillemoe KD; Bassi C; Fernàndez-Del Castillo C; Salvia R
Ann Surg Oncol; 2020 Oct; 27(10):3898-3912. PubMed ID: 32307617
[TBL] [Abstract][Full Text] [Related]
30. Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma.
Kim HJ; Park MS; Lee JY; Han K; Chung YE; Choi JY; Kim MJ; Kang CM
Cancer Res Treat; 2019 Jan; 51(1):24-33. PubMed ID: 29397657
[TBL] [Abstract][Full Text] [Related]
31. Preoperative predictors for early and very early disease recurrence in patients undergoing resection of pancreatic ductal adenocarcinoma.
Daamen LA; Dorland G; Brada LJH; Groot VP; van Oosten AF; Besselink MG; Bosscha K; Bonsing BA; Busch OR; Cirkel GA; van Dam RM; Festen S; Groot Koerkamp B; Haj Mohammad N; van der Harst E; de Hingh IHJT; Intven MPW; Kazemier G; Los M; de Meijer VE; Nieuwenhuijs VB; Roos D; Schreinemakers JMJ; Stommel MWJ; Verdonk RC; Verkooijen HM; Molenaar IQ; van Santvoort HC;
HPB (Oxford); 2022 Apr; 24(4):535-546. PubMed ID: 34642090
[TBL] [Abstract][Full Text] [Related]
32. Post-Whipple imaging in patients with pancreatic ductal adenocarcinoma: association with overall survival: a multivariate analysis.
Elmi A; Murphy J; Hedgire S; McDermott S; Abtahi SM; Halpern E; Fernandez-Del Castillo C; Harisinghani M
Abdom Radiol (NY); 2017 Aug; 42(8):2101-2107. PubMed ID: 28293721
[TBL] [Abstract][Full Text] [Related]
33. Lexicon for adrenal terms at CT and MRI: a consensus of the Society of Abdominal Radiology adrenal neoplasm disease-focused panel.
Glazer DI; Mayo-Smith WW; Remer EM; Caoili EM; Song JH; Taffel MT; Lee JT; Brook OR; Shinagare AB; Blake MA; Elsayes KM; Schieda N; Westphalen AC; Campbell MJ; Corwin MT
Abdom Radiol (NY); 2023 Mar; 48(3):952-975. PubMed ID: 36525050
[TBL] [Abstract][Full Text] [Related]
34. Portal encasement: Significant CT findings to diagnose local recurrence after pancreaticoduodenectomy for pancreatic cancer.
Noie T; Harihara Y; Akahane M; Kazaoka J; Nagao A; Sato S; Watanabe K; Nara S; Furushima K; Yoshioka R; Yamagata Y; Takeshita E; Okuyama T; Sameshima S; Oya M
Pancreatology; 2018 Dec; 18(8):1005-1011. PubMed ID: 30241869
[TBL] [Abstract][Full Text] [Related]
35. Structured CT reporting of pancreatic ductal adenocarcinoma: impact on completeness of information and interdisciplinary communication for surgical planning.
Malik RF; Hasanain A; Lafaro KJ; He J; Narang AK; Fishman EK; Zaheer A
Abdom Radiol (NY); 2022 Feb; 47(2):704-714. PubMed ID: 34800162
[TBL] [Abstract][Full Text] [Related]
36. The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis.
Guo C; Zhuge X; Wang Q; Xiao W; Wang Z; Wang Z; Feng Z; Chen X
Cancer Imaging; 2018 Oct; 18(1):37. PubMed ID: 30333055
[TBL] [Abstract][Full Text] [Related]
37. Appraisal of 5-year recurrence-free survival after surgery in pancreatic ductal adenocarcinoma.
Yoon SJ; Shin SH; Yoon SK; Jung JH; You Y; Han IW; Choi DW; Heo JS
J Hepatobiliary Pancreat Sci; 2021 Mar; 28(3):287-296. PubMed ID: 32790012
[TBL] [Abstract][Full Text] [Related]
38. Does the interval from imaging to operation affect the rate of unanticipated metastasis encountered during operation for pancreatic adenocarcinoma?
Glant JA; Waters JA; House MG; Zyromski NJ; Nakeeb A; Pitt HA; Lillemoe KD; Schmidt CM
Surgery; 2011 Oct; 150(4):607-16. PubMed ID: 22000171
[TBL] [Abstract][Full Text] [Related]
39. Use of imaging during symptomatic follow-up after resection of pancreatic ductal adenocarcinoma.
Groot VP; Daamen LA; Hagendoorn J; Borel Rinkes IHM; van Santvoort HC; Molenaar IQ
J Surg Res; 2018 Jan; 221():152-160. PubMed ID: 29229122
[TBL] [Abstract][Full Text] [Related]
40. DeepPrognosis: Preoperative prediction of pancreatic cancer survival and surgical margin via comprehensive understanding of dynamic contrast-enhanced CT imaging and tumor-vascular contact parsing.
Yao J; Shi Y; Cao K; Lu L; Lu J; Song Q; Jin G; Xiao J; Hou Y; Zhang L
Med Image Anal; 2021 Oct; 73():102150. PubMed ID: 34303891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
